FLAGSTAFF, Ariz., Sept. 4, 2019 /PRNewswire/ -- SenesTech, Inc.
(NASDAQ: SNES), a developer of proprietary technologies for
managing animal pest populations through fertility control,
announced today that it will be presenting at the 21st Annual
Global Investment Conference Sponsored by H.C. Wainwright in
New York City.
The SenesTech presentation will be made by Ken Siegel, CEO, and Tom
Chesterman, CFO, on Monday, September
9th at 4:15 pm Eastern
Time.
A live audio webcast of the H.C. Wainwright Conference
presentation can be accessed by visiting 'Events and Presentations'
in the Investor Relations section on the Company's website at
www.senestech.com or here. An archived replay of the webcast will
be available on the Company's website after the conference.
Additionally, a copy of the slide presentation SenesTech will be
referencing during the conference will be available in the Investor
Relations section of the Company's website.
Investors interested in arranging one-on-one meetings should
contact your conference representative. Conversely, you may also
call or email Lytham Partners at (602) 889-9700 or
senestech@lythampartners.com.
About SenesTech
SenesTech is changing the paradigm of pest management by
targeting the root cause of the problem: reproduction.
ContraPest® is an innovative technology with an approach that
targets the reproductive capabilities of both sexes in rat
populations, inducing egg loss in female rats and impairing sperm
development in males. Using a proprietary bait delivery method,
ContraPest® is dispensed in a highly palatable liquid formulation
that promotes sustained consumption by rat communities. ContraPest®
is designed, formulated and dispensed to be low hazard for handlers
and non-target species such as wildlife, livestock and pets, where
the active ingredients break down rapidly.
We believe ContraPest® will establish a new paradigm in rodent
control, resulting in a decreased reliance on lethal options. For
more information visit the SenesTech website at
www.senestech.com.
Safe Harbor Statement
This release contains
"forward-looking statements" within the meaning of Section 27A of
the Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended and such
forward-looking statements are made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995.
"Forward-looking statements" describe future expectations, plans,
results, or strategies and are generally preceded by words such as
"may," "future," "plan" or "planned," "will" or "should,"
"expected," "anticipates," "draft," "eventually" or "projected."
You are cautioned that such statements are subject to a multitude
of risks and uncertainties that could cause future circumstances,
events, or results to differ materially from those in the
forward-looking statements, including the risks that actual results
may differ materially from those projected in the forward-looking
statements as a result of various factors and other risks
identified in our filings with the Securities and Exchange
Commission. Forward looking statements include, but are not limited
to, our expectation regarding sales commitments, our expectation
regarding the conversion of sales commitments and programs to
revenue, our belief that our product is more humane, less harmful
to the environment and more effective than traditional methods, and
our belief that ContraPest will establish a new paradigm in rodent
control without environmental effects of rodenticides. All
forward-looking statements contained in this press release speak
only as of the date on which they were made and are based on
management's assumptions and estimates as of such date. We do not
undertake any obligation to publicly update any forward-looking
statements, whether as a result of the receipt of new information,
the occurrence of future events or otherwise.
CONTACT:
Investor: Robert Blum,
Joe Dorame, Joe Diaz, Lytham Partners, LLC, 602-889-9700,
senestech@lythampartners.com
Company: Tom Chesterman, Chief
Financial Officer, SenesTech, Inc., 928-779-4143
View original content to download
multimedia:http://www.prnewswire.com/news-releases/senestech-to-present-at-the-21st-annual-global-investment-conference-on-september-9-2019-300911203.html
SOURCE SenesTech, Inc.